Stockreport

Xenon Pharmaceuticals Inc (XENE) Reports Full Year and Q4 2023 Financial Results [Yahoo! Finance]

Xenon Pharmaceuticals Inc. - Common Shares  (XENE) 
Last xenon pharmaceuticals inc. - common shares earnings: 11/5 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.xenon-pharma.com
PDF Research and Development: Increased to $167.5 million in 2023, up from $105.8 million in 2022. General and Administrative Expenses: Rose to $46.5 million in 2023, fro [Read more]